TR10
Laboratory-grade research compound, prepared and packaged under controlled conditions. Not for human or animal consumption. For in vitro research use only.
Related compounds
Research Material Overview
Tirzepatide is a synthetic peptide analog engineered as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIPR) and glucagon-like peptide-1 (GLP-1R) receptors. It incorporates a C20 fatty dicarboxylic acid side chain that supports albumin binding and prolonged pharmacokinetic behavior in research models. CloudComps supplies tirzepatide as a lyophilized research material for in vitro and laboratory investigation only.
Physical Description
Supplied as a white to off-white lyophilized powder in a sealed, sterile-capped glass vial. The material is hygroscopic; avoid exposure to ambient moisture. Reconstitute with an appropriate sterile, research-grade solvent prior to in vitro use.
Molecular Information
- Appearance
- White to off-white lyophilized powder
- Molecular formula
- C225H348N56O88
- Molecular weight
- ~4814 g/mol
- CAS number
- 2023788-19-2
- Classification
- 39-amino-acid synthetic peptide; dual GIP/GLP-1 receptor agonist with C20 fatty acid side chain
Purity & Testing Information
Reported purity of ≥ 99% is determined by RP-HPLC under the analytical conditions specified on the lot-specific Certificate of Analysis. The accompanying documentation includes the chromatographic method, detection conditions, and mass spectrometry data. Purity reflects the proportion of analyzed material attributed to the target peptide and should be interpreted alongside identity confirmation rather than in isolation.
Available Documentation
- Lot-specific Certificate of Analysis (COA)
- RP-HPLC chromatogram with purity calculation
- Mass spectrometry (LC-MS) data
- Solubility and reconstitution guidance
- Storage and handling documentation
Storage Information
Store lyophilized material at -20°C in the original sealed vial, protected from light. Following reconstitution, aliquot into single-use volumes and store at 2-8°C for short-term use or -20°C for longer storage. Minimize repeated freeze-thaw cycles. Researchers should verify stability under their specific experimental conditions.
Frequently Asked Questions
What distinguishes tirzepatide from single-receptor GLP-1 analogs?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, engaging both increin pathways simultaneously. This dual activity, combined with its albumin-binding fatty acid side chain, is the basis for its distinct pharmacokinetic profile in research models.
Is this material intended for human or clinical use?
No. Tirzepatide supplied by CloudComps is for in vitro laboratory and scientific research only and is not for human or veterinary consumption.
What does the reported purity value represent?
The ≥ 99% purity reflects the proportion of analyzed material attributed to the target peptide under the stated RP-HPLC method. It should be reviewed alongside the complete COA and identity information rather than relied upon in isolation.
Related Research Resources
Research-Use Disclaimer
Tirzepatide is intended exclusively for in vitro laboratory and scientific research purposes. It is not for human or veterinary consumption, clinical use, or diagnostic application. Researchers should review the complete analytical documentation, handle the material in accordance with appropriate laboratory practices, and comply with all applicable regulations. Statements regarding receptor activity or research interest refer to preclinical study contexts and do not imply suitability for any particular application.